| Literature DB >> 1647247 |
K Saito1, A Lackner, S P Markey, M P Heyes.
Abstract
Increased concentrations of the neuroactive kynurenine pathway metabolites, quinolinic acid (QUIN) and kynurenic acid (KYNA), occur in the CSF of humans infected with the human immunodeficiency virus and macaques infected with retroviruses, including the D/1/California serotype. In the present study, increased activity of indoleamine-2,3-dioxygenase (IDO), the first enzyme of the kynurenine pathway, occurred in cerebral cortex and lung of macaques with clinical SAIDS. Such increases provide a mechanism to accelerate the formation of kynurenine pathway metabolites in both systemic tissues and the central nervous system.Entities:
Mesh:
Substances:
Year: 1991 PMID: 1647247 DOI: 10.1016/0006-8993(91)90536-5
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252